newsfilter
← Latest News
GlobeNewswire·

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE studyPUL 2.0 year-over-year decline attenuated to approximately 1 pointFindings to be presented alongside previously